Skip to main content

Want a detailed portfolio tracker?

Oculis (OCS) P/E (2023 - 2026)

Oculis (OCS) P/E from Mar 2, 2023 to Jun 3, 2026. The TTM Oculis (OCS) P/E is -6.06. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Oculis (OCS)

YearP/EChange
2026-6.06-29.59%
2025-8.61+20.91%
2024-7.12+75.98%
2023-4.05N/A

Comparison Oculis (OCS) P/E with competitors

Oculis (OCS) P/E is -6.06.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.69%
ENLVEnlivex Therapeutics Ltd0.15-102.48%
FGENFibroGen Inc0.24-103.96%
TRAWTraws Pharma Inc0.47-107.80%
FBIOFortress Biotech Inc0.71-111.64%
CHRSCoherus Biosciences Inc0.98-116.13%
ORMPOramed Pharmaceuticals Inc1.47-124.29%
AGENAgenus Inc2.05-133.77%
VIVSVivoSim Labs Inc2.54-141.81%
INVAInnoviva Inc3.19-152.57%
CRMDCorMedix Inc3.65-160.11%
ABEOAbeona Therapeutics Inc4.20-169.33%
VXRTVaxart Inc4.26-170.26%
CVACCureVac N.V.4.45-173.30%
SRPTSarepta Therapeutics Inc4.62-176.24%
GLPGGalapagos NV4.86-180.11%
RIGLRigel Pharmaceuticals4.92-181.11%
ZVRAZevra Therapeutics Inc4.97-182.01%
ABUSArbutus Biopharma Corp5.69-193.88%
CGENCompugen Ltd7.38-221.75%
AUPHAurinia Pharmaceuticals Inc9.25-252.54%
ACADAcadia Pharmaceuticals Inc9.59-258.09%
OMEROmeros Corporation9.88-262.96%
PLXProtalix BioTherapeutics Inc9.91-263.38%
SPROSpero Therapeutics Inc10.73-276.99%
ADMAAdma Biologics Inc11.33-286.82%
SVASinovac Biotech Ltd11.44-288.56%
TBPHTheravance Biopharma Inc11.78-294.17%
HRMYHarmony Biosciences Holdings Inc12.18-300.83%
TGTXTG Therapeutics Inc13.18-317.30%
INCYIncyte Corp13.38-320.64%
SABSSAB Biotherapeutics Inc14.06-331.79%
XOMAXOMA Corp14.95-346.42%
REGNRegeneron Pharmaceuticals Inc14.98-347.00%
PBYIPuma Biotechnology Inc15.05-348.15%
EXELExelixis Inc15.79-360.43%
NAGENiagen Bioscience Inc16.35-369.66%
CPRXCatalyst Pharmaceuticals Inc17.34-385.98%
MDXGMimedx Group Inc17.38-386.49%
ARGXArgen X SE23.07-480.41%
HALOHalozyme Therapeutics Inc23.20-482.53%
XOMAOXOMA Corp25.34-517.89%
VRTXVertex Pharmaceuticals Inc25.66-523.02%
XOMAPXOMA Corp25.67-523.25%
CTMXCytomX Therapeutics Inc25.70-523.71%
ASNDAscendis Pharma A/S26.35-534.53%
RPRXRoyalty Pharma plc - Class A27.50-553.35%
SLNOSoleno Therapeutics Inc29.02-578.41%
LGNDLigand Pharmaceuticals Inc - Class B30.19-597.72%
BMRNBiomarin Pharmaceutical Inc37.51-718.42%
APLSApellis Pharmaceuticals Inc39.02-743.39%
KRYSKrystal Biotech Inc39.70-754.54%
GMABGenmab40.20-762.88%
ONCBeiGene Ltd67.03-1205.15%
TECHBio-Techne Corp68.59-1231.01%
VCELVericel Corp80.63-1429.43%
PHARPharming Group N.V.87.74-1546.67%
ALNYAlnylam Pharmaceuticals Inc124.93-2159.93%
TLXTelix Pharmaceuticals Ltd139.89-2406.54%
CORTCorcept Therapeutics Inc158.39-2711.55%